Author:
Weiss M B,Vitolo M I,Mohseni M,Rosen D M,Denmeade S R,Park B H,Weber D J,Bachman K E
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference49 articles.
1. Meta-analysis group in cancer (1998). Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16: 301–308.
2. Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE et al. (1996). Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2: 811–814.
3. Agarwal ML, Agarwal A, Taylor WR, Stark GR . (1995). p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92: 8493–8497.
4. Bachman KE, Blair BG, Brenner K, Bardelli A, Arena S, Zhou S et al. (2004). p21(WAF1/CIP1) mediates the growth response to TGF-beta in human epithelial cells. Cancer Biol Ther 3: 221–225.
5. Bischoff FZ, Yim SO, Pathak S, Grant G, Siciliano MJ, Giovanella BC et al. (1990). Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res 50: 7979–7984.